LB1576 Applying a novel computational drug-repurposing system to psoriasis
We have recently developed a novel computational drug discovery system (DrugPredict) that simultaneously performs in silico target-based and phenotypic screening on half a million compounds. We have previously applied DrugPredict to identify repurposed candidate drugs for ovarian cancer and experimentally validated that a commonly prescribed pain medication can be used to kill ovarian cancer cells. In the current study, we retargeted DrugPredict to identify repurposed drug candidates for the dermatologic condition psoriasis.
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: Q. Wang, N. Ward, T. McCormick, K. Cooper, R. Xu Tags: Pharmacology and Drug Development Source Type: research
More News: Cancer | Cancer & Oncology | Dermatology | Drugs & Pharmacology | Ovarian Cancer | Ovaries | Pain | Psoriasis | Skin | Study